Medical Oncologist
CION Cancer Clinics
Hepatitis B reactivation during cancer treatment: how to prevent it | CION Cancer Clinics
Cancer treatment can let a quiet hepatitis B infection become active again and inflame the liver. In most people this can be prevented with a blood test before treatment and a preventive antiviral tablet for those who need it. This page explains who is at risk, which treatments matter most, what should happen before your first dose, and which signs mean you should call your team the same day. At CION Cancer Clinics, our specialists help you understand your own risk and plan regular liver checks that fit it.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can cancer treatment wake up hepatitis B, and can it be prevented?
- Which treatments and which people carry the most risk?
- What should happen before and during treatment?
- What do the hepatitis B test words mean?
- Four things families believe about hepatitis B and chemotherapy
- What this page cannot tell you
- Common questions about hepatitis B reactivation
The short answer
Can cancer treatment wake up hepatitis B, and can it be prevented?
Yes, and in most people it can be prevented. Chemotherapy, steroids, some targeted drugs and some immunotherapy weaken the body's control over the hepatitis B virus. The virus can then multiply again and inflame the liver. A blood test before treatment, and a preventive antiviral tablet for those who need one, stops most of these flares before they start.
Why the virus is still there
Hepatitis B does not fully leave the body, even in people whose blood looks clear. A copy of the virus stays quietly inside liver cells. The immune system keeps it in check for years. When treatment lowers that guard, the virus can return. This is called reactivation, and the inflammation it causes is called a flare.
Who this page is for
It is for anyone about to start cancer treatment who has hepatitis B, once had it, or does not know. That includes people with liver cancer caused by hepatitis B, and people with an entirely different cancer, such as lymphoma or breast cancer, who carry the virus. Hepatitis B is controlled with medicine, not removed, so the question matters every time a new treatment starts.
A flare is not a sign that the cancer has spread. It is the virus, and it has its own treatment.Weighing the risk
Which treatments and which people carry the most risk?
Risk depends on two things together: what your blood test shows, and how strongly the treatment dampens the immune system.
Your hepatitis B status
People who test positive for HBsAg, the surface marker of current infection, carry the highest risk. People with a negative HBsAg but a positive anti-HBc, meaning a past infection, carry a lower but real risk.
Higher risk when
- HBsAg is positive
- The viral load is already detectable
- The liver already has cirrhosis
Treatments that lower immunity strongly
Rituximab and similar drugs used in lymphoma carry the highest risk, even after past infection. High-dose steroids, stem cell transplant and intensive chemotherapy follow close behind.
The rituximab and hepatitis B page covers that drug in detail.Treatments used for liver cancer
Standard chemotherapy, TACE (chemotherapy delivered into the liver's blood supply), targeted tablets and immunotherapy can all trigger a flare. Immunotherapy works differently, but flares have been seen, so the same checks apply.
Why a flare matters more with liver cancer
A liver already scarred or carrying a tumour has less in reserve. A flare can force treatment to pause, and pausing cancer treatment is exactly what everyone wants to avoid.
Not sure whether this applies to you?
Ask an oncologistWhat prevention looks like
What should happen before and during treatment?
Test before the first dose
Guidelines advise checking HBsAg and anti-HBc in everyone before chemotherapy or immune-lowering treatment, not only in people thought to be at risk. Many carriers in India have never been told. The screening before chemotherapy page explains the tests.
Measure the virus if a test is positive
A viral load test (HBV DNA) and liver blood tests set a starting point. CION arranges these tests through its diagnostic partners and shares the results with a hepatologist.
Start the antiviral early
For most people who are HBsAg positive, a preventive antiviral tablet such as entecavir or tenofovir is started before cancer treatment or at the same time. The hepatologist or physician decides which medicine and for how long.
Watch closely if no tablet is started
Some people with past infection only are monitored with regular blood tests instead. If the virus reappears, the antiviral starts then.
Keep taking it after treatment ends
Flares can happen long after the last dose of cancer treatment. Do not stop the antiviral on your own. Your doctor will say when it is safe.
!
Signs of a flare that cannot wait
If you are on cancer treatment and have hepatitis B, call your treating team the same day for yellow eyes or skin, dark urine, pale stools, new pain under the right ribs, or tiredness far worse than usual. If there is confusion, drowsiness, vomiting blood or jaundice with fever, go to hospital today and say you have hepatitis B and are on cancer treatment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
What do the hepatitis B test words mean?
- HBsAg
- The surface marker of the virus. Positive means the infection is present now. Most people in this group need a preventive antiviral.
- Anti-HBc
- An antibody showing you have met the virus at some point. Positive with a negative HBsAg is called past or occult hepatitis B.
- Anti-HBs
- Protection, either from a past infection or from the vaccine. It lowers the chance of reactivation but does not remove it.
- HBV DNA (viral load)
- How much virus is in the blood. A rising number during treatment is the earliest sign of reactivation, often before any symptom.
- ALT
- A liver enzyme in the routine blood test. A sharp rise suggests the liver is inflamed.
Commonly believed
Four things families believe about hepatitis B and chemotherapy
"My hepatitis B is inactive, so it will not matter."
Inactive means the immune system is holding the virus down. Cancer treatment can loosen that hold. Inactive carriers are exactly the group that preventive antivirals protect.
"I was tested years ago and it was negative."
An old test may have checked only HBsAg. Past infection shows up on anti-HBc, which many routine panels leave out. Ask for both before treatment.
"Adding another tablet will weaken the chemotherapy."
Antivirals do not reduce the effect of cancer treatment. They protect the liver so that the cancer treatment can carry on as planned.
"We should hide the hepatitis B so treatment is not refused."
Hepatitis B is not a reason to refuse cancer treatment. Telling the team is what keeps you safe. Having the virus is not anyone's fault, and nobody at CION will treat it as one.
Being straight with you
What this page cannot tell you
It cannot tell you whether you personally need an antiviral, which one, or for how long. Those decisions belong to a hepatologist or physician who has seen your full hepatitis B panel, your liver tests and the exact cancer plan. At CION, the oncologist and the tumour board review the plan, and antiviral care is coordinated with a partner hepatologist.
It cannot read your report for you
The same marker can mean different things in different combinations. The hepatitis B report page explains the patterns, but your own result should be read by the doctor treating you.
Who this does not apply to
If your HBsAg and anti-HBc are both negative, reactivation is not a risk for you, and you may only need the vaccine. If your liver cancer is already being treated while the virus is active, the active hepatitis B page is the closer match.
If your treatment has started and nobody has checked for hepatitis B, ask your team this week.Questions we are asked
Common questions about hepatitis B reactivation
Is reactivation common?
It is common enough in people who are HBsAg positive that guidelines advise a preventive antiviral for most of them before strong treatment. It is less common after past infection only. With testing and early antivirals, most flares are prevented, which is why the test matters more than the statistics.
Can a flare be serious?
Yes. Most flares are picked up on blood tests and settle with antiviral treatment. A small number cause severe liver failure, especially in a liver that already has cirrhosis. That is the reason testing is done before treatment rather than after symptoms appear.
Will my cancer treatment be delayed for this?
Usually not. The tests are simple blood tests, and the antiviral can usually start alongside cancer treatment. Your team will tell you if your liver tests mean treatment should wait. A short wait to protect the liver is safer than a flare midway through treatment.
Does immunotherapy carry the same risk as chemotherapy?
The way it works is different, and the risk seems lower, but flares have been reported. The same screening applies before the first dose. The hepatitis and immunotherapy page explains what changes when you have the virus.
Are entecavir and tenofovir available in India?
Yes. Both are available in India as tablets, and generic versions are widely sold. The choice between them depends on your kidneys, bones, other medicines and past treatment. Your hepatologist or physician will choose, and will tell you how to take it.
How long after treatment do I keep taking the antiviral?
That depends on the cancer treatment you had and your hepatitis B status, and some people stay on it long term. Flares can still happen after cancer treatment ends. The stopping hepatitis B medicine page explains why stopping early is risky.
Should my family be tested too?
Yes, if you have hepatitis B. It often passes within families, and many relatives do not know they carry it. Testing is not about blame. Relatives who test negative can be vaccinated, and those who test positive can be monitored and protected.
Who do I tell before my treatment starts?
Tell your oncologist and bring any old hepatitis reports and medicine lists. If you are unsure whether you have been tested properly, call the CION helpline. The team can arrange the tests and coordinate with a hepatologist before your first dose.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- AASLD — Practice Guidelines
- NIDDK — Hepatitis B - NIDDK
- NHS — Hepatitis B
- National Cancer Institute — Chemotherapy to Treat Cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Systemic treatment with hepatitis B still activeIf your liver cancer is treated while the virus is activeOccult hepatitis B: positive anti-HBc, negative HBsAgThe past-infection result that still needs watchingStopping hepatitis B medicine: why it is riskyBefore you think about coming off the antiviralChemotherapy with hepatitis B or CHow chemotherapy is planned around the virus
Talk to us
Starting treatment and not sure you were tested for hepatitis B?
Tell us what treatment is planned and share any hepatitis reports you have. We can arrange the right tests and coordinate antiviral care with a hepatologist before you begin. One helpline serves every CION centre.